Back
Roivant Sciences 10K Form
Buy
55
ROIV
Roivant Sciences
Last Price:
11.23
Seasonality Move:
18%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ROIV News And Ratings
See the #1 stock for the next 7 days that we like better than ROIV
ROIV Financial Statistics
Sales & Book Value
| Annual Sales: | $61.28M |
|---|---|
| Cash Flow: | $-210.81M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $7.57 |
| Price / Book: | 1.49 |
Profitability
| EPS (TTM): | 5.20000 |
|---|---|
| Net Income (TTM): | $4.47B |
| Gross Margin: | $48.15M |
| Return on Equity: | 181.87% |
| Return on Assets: | 138.65% |
Roivant Sciences Earnings Forecast
Key Roivant Sciences Financial Ratios
- The Gross Profit Margin over the past 3 years for ROIV is 78.58%.
- The Selling, General & Administrative Expenses for ROIV have been equal to 979.94% of Gross Profit Margin.
- The Research & Development expenses have been 857.07% of Revenue.
- The Interest Expense is -2.77% of Operating Income.
- The Net Earning history of ROIV is -1,646.59% of Total Revenues.
- Per Share Earnings over the last 3 years have been positive in 0 years.
Roivant Sciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ROIV |
| Website: | roivant.com |
Debt
| Debt-to-Equity Ratio: | 0.07 |
|---|---|
| Current Ratio: | 27.79 |
| Quick Ratio: | 27.5 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ROIV Technical Analysis vs Fundamental Analysis
Buy
55
Roivant Sciences (ROIV)
is a Buy
Is Roivant Sciences a Buy or a Sell?
-
Roivant Sciences stock is rated a Buy
The current Roivant Sciences [ROIV] share price is $11.23. The Score for ROIV is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.